Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Revenue

1 Followers

Statistics Market Cap Revenue

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Revenue

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H had a revenue of 620.96M in the quarter ending Jun 30, 2025, with 8.95%. This bring the company's revenue in the last twelve months to 1.19B, Decreased 21.47%. In the fiscal year ending Dec 31, 2024, Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H had annual revenue of 980.45M with 36.76% growth.

Revenue (ttm)

1.19B

Revenue Growth

48.38%

P/S Ratio

26.46

Revenue/Employee

HK$877,756

Employees

1,117

Market Cap

HK$25.94B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2024	980.45M	263.54M	+36.76%
Dec 31, 2023	716.91M	183.03M	+34.28%
Dec 31, 2022	533.88M	179.33M	+50.58%
Dec 31, 2021	354.56M	101.01M	+39.84%
Dec 31, 2020	253.54M	―	―